#Balloon Valvuloplasty Device Market

[univdatosmarket]

The balloon valvuloplasty device market was valued at USD 2251.18 Million and is expected to grow at a strong CAGR of around 4.7% during the forecast period (2023-2030) owing to rising prevalence of cardiovascular diseases.

[stevenwilliam12]

Emerging Trends in Balloon Valvuloplasty Devices: 2030 Market Forecast

Balloon valvuloplasty, a minimally invasive procedure used to treat stenotic heart valves, is undergoing rapid transformation. With advancements in medical technology and increasing patient demand for non-surgical interventions, the global balloon valvuloplasty devices market is set for significant growth. Market forecasts predict that by 2030, the sector will see both technological innovation and market expansion, driven by key factors such as an aging population, regulatory approvals, and emerging healthcare markets.

Technological Innovations and Product Development

Advancements in materials and catheter design are leading the way in the development of next-generation valvuloplasty balloons. Companies are introducing balloons with enhanced flexibility and improved radial force, ensuring safer and more effective dilation of narrow valves. Additionally, biocompatible coatings and drug-eluting balloon technologies are being explored to reduce restenosis risk and improve long-term outcomes. Innovations in imaging-guided catheter placement are also enhancing the precision of these procedures.

Market Drivers: Aging Population and Cardiovascular Diseases

With the global population aging rapidly, conditions like aortic stenosis are becoming more prevalent. Balloon valvuloplasty offers an alternative for elderly or high-risk patients who cannot undergo open-heart surgery. This demographic trend is expected to drive the demand for valvuloplasty devices over the next decade, with growing numbers of patients seeking minimally invasive treatments.

Regulatory Approvals and Clinical Trials

The introduction of newer devices often hinges on regulatory approvals. As more devices undergo successful clinical trials, regulatory bodies like the FDA and European Medicines Agency are fast-tracking approvals, facilitating quicker access to life-saving interventions. These streamlined pathways will encourage further product innovation and market penetration.

Opportunities in Emerging Markets

Emerging economies in Asia, Latin America, and the Middle East present significant growth potential, given their increasing healthcare infrastructure investments. As awareness of valvuloplasty grows and more hospitals adopt these procedures, demand for advanced balloon technologies will increase.

In conclusion, the balloon valvuloplasty devices market is poised for robust growth by 2030, propelled by technological advancements, demographic shifts, regulatory support, and opportunities in new markets. Industry players focusing on innovation and strategic partnerships will be well-positioned to capitalize on these emerging trends.

Conclusion:

The balloon valvuloplasty device market size is poised for substantial growth by 2030, driven by increasing cardiovascular disease prevalence and technological advancements. With key players enhancing product offerings and expanding their reach, the market is expected to see significant opportunities, particularly in minimally invasive procedures for heart valve treatment.

Latest Reports Offered By DelveInsight:

CD47 Antigen Inhibitors Market

DelveInsight’s “CD47 Targeting Therapeutics Market – Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the CD47 inhibitors, historical and forecasted epidemiology, competitive landscape as well as the CD47 inhibitors market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Hypercoagulability Market

DelveInsight's "Hypercoagulability- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypercoagulability, historical and forecasted epidemiology as well as the Hypercoagulability market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

.

Point Of Care Glucose Testing Market

DelveInsight’s ‘Point of Care Glucose Testing - Market Insight, Competitive Landscape and Market Forecast, 2030’ report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Substance Drug Abuse Market

DelveInsight's "Substance Drug Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Tongue Cancer Market

DelveInsight's "Tongue Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tongue Cancer, historical and forecasted epidemiology as well as the Tongue Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Trastuzuma Biosimilar

DelveInsight’s, “Trastuzumab Biosimilar Insight, 2024” report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Trastuzumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

[neha24blog]

Balloon Valvuloplasty Devices Market Outlook On The Basis Of Application, End-Use, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 4 Oct 2024: The Report Balloon Valvuloplasty Devices Market Size, Share & Trends Analysis Report By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 – 2030 The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of…

[linhgd9]

Global Balloon Valvuloplasty Device Market 2021 With (COVID-19) Impact Analysis, Industry Demand, Top Trends, Forecast 2028 – By MRS

“A SWOT Analysis of Balloon Valvuloplasty Device, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down.”

The market report, titled “Balloon Valvuloplasty Device Market“, is a broad research dependent on Balloon Valvuloplasty Device market, which examines the escalated structure of the present market all around the world. Planned by the sufficient orderly system, for example, SWOT investigation, the Balloon Valvuloplasty Device market report demonstrates an aggregate appraisal of overall Balloon Valvuloplasty Device market alongside the noteworthy players Terumo, Edwards, Palex Medical SA, Tokai Medical Products Inc, Boston, Toray of the market.

Apply here for the FREE sample copy of the report @: https://www.marketresearchstore.com/sample/balloon-valvuloplasty-device-market-814285

The conjecture for CAGR (Compound Annual Growth Rate) is expressed by the Balloon Valvuloplasty Device Market report in the terms of proportion for the particular time length. This will likewise assist the client with understanding and settle on an exact decision based on an expected diagram. Furthermore, The report presents a detailed segmentation 23 mm, 26 mm, 29 mm, Market Trend by Application Hospitals, Ambulatory Surgery Centres of the global market based on technology, product type, application, and various processes and systems.

Income age and assembling scale are the two superior divisions on which the Balloon Valvuloplasty Device market is reliant. An evaluation of the market’s fundamental segment and the geological territories around the globe is additionally canvassed in this report. Different Balloon Valvuloplasty Device market factors, for example, development, confinements, and the arranged attributes of each point have been accounted profoundly. Based on this qualities, the Balloon Valvuloplasty Device market report predicts the fate of the market all around.

The additional geographical segments are also mentioned in the empirical report.

North America: U.S., Canada, Rest of North America Europe: UK, Germany, France, Italy, Spain, Rest of Europe Asia Pacific: China, Japan, India, Southeast Asia, North Korea, South Korea, Rest of Asia Pacific Latin America: Brazil, Argentina, Rest of Latin America Middle East and Africa: GCC Countries, South Africa, Rest of Middle East & Africa

The production and distribution up-scales and downscales along with the market share can enlighten the readers with the overall market growth and development. The entire colossal of fine points scripted in the report provides the entire gist of the report that signifies the market expansion and sales volume or value.

Read Detailed Index of full Research Study at:: https://www.marketresearchstore.com/market-insights/balloon-valvuloplasty-device-market-814285

This report holds every last part of the global market for this particular area, going from the essential market information to numerous critical criteria, according to which the Balloon Valvuloplasty Device market is institutionalized. The principle working areas of the Balloon Valvuloplasty Device market are additionally secured dependent on their execution. The Balloon Valvuloplasty Device market report covers research of present strategies, directions, and market chain. Considering different variables like merchandise, their chain of generation, chief producers, and supply & order, value, for business is composed in this report.

The report likewise contains as far as possible, attributes of interest and supply, pinpoint examination, and the consecutive introduction of the Balloon Valvuloplasty Device market around the world.

Impact Of COVID-19

The most recent report includes extensive coverage of the significant impact of the COVID-19 pandemic on the Heated Jacket division. The coronavirus epidemic is having an enormous impact on the global economic landscape and thus on this special line of business. Therefore, the report offers the reader a clear concept of the current scenario of this line of business and estimates the aftermath of COVID-19.

There are 15 Chapters to display the Global Balloon Valvuloplasty Device market

Chapter 1, Definition, Specifications and Classification of Balloon Valvuloplasty Device, Applications of Balloon Valvuloplasty Device, Market Segment by Regions; Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure; Chapter 3, Technical Data and Manufacturing Plants Analysis of Balloon Valvuloplasty Device, Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis; Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment); Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Balloon Valvuloplasty Device Segment Market Analysis (by Type); Chapter 7 and 8, The Balloon Valvuloplasty Device Segment Market Analysis (by Application) Major Manufacturers Analysis of Balloon Valvuloplasty Device ; Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type 23 mm, 26 mm, 29 mm, Market Trend by Application Hospitals, Ambulatory Surgery Centres; Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis; Chapter 11, The Consumers Analysis of Global Balloon Valvuloplasty Device ; Chapter 12, Balloon Valvuloplasty Device Research Findings and Conclusion, Appendix, methodology and data source; Chapter 13, 14 and 15, Balloon Valvuloplasty Device sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Enquire Here Get customization & check discount for report @: https://www.marketresearchstore.com/inquiry/balloon-valvuloplasty-device-market-814285

Reasons for Buying Balloon Valvuloplasty Device market

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Market Research Store

At Market Research Store, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Market Research Store committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 24×7.

Ask Queries/Buy Report Directly by Contacting Us @ sales@marketresearchstore.com

Contact US:

Market Research Store 3422 SW 15 Street,Suit #8138, Deerfield Beach,Florida 33442, USA Tel: +1-386-310-3803GMT Tel: +49-322 210 92714 Website: https://www.marketresearchstore.com

  from NeighborWebSJ https://ift.tt/3k4a5Nb via IFTTT

from WordPress https://ift.tt/3xywy8Q via IFTTT

[rishabh3210blog]

Global Rheumatic heart disease Market Trends | Segmentation, Outlook, Industry Report to 2021-2027

The global rheumatic heart disease market is anticipated to grow at a CAGR of 6.0% during the forecast period (2021-2027).  Global rheumatic heart disease is segmented based on treatment, type, diagnostics tests, and end-users. Based on the type, the global rheumatic heart disease market is segmented into valve, myocarditis, and pericarditis. Besides, the valve is bifurcated into the aortic valve and mitral valve. The valve segment of the global rheumatic heart disease market is projected to hold the most substantial share over the forecast period. The factor that is driving the growth of segment includes rising FDA approvals, the market players initiatives, among others. For instance, in December 2020, In India, Abbott has announced the launch of its clip-delivery system, a minimally invasive heart valve repair product for mitral regurgitation. The system connects parts of the mitral valve's leaflets, or flaps, to minimize blood backflow (known as mitral regurgitation, or MR), allowing the heart to pump oxygenated blood more effectively.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/rheumatic-heart-disease-market

In March 2021, Keystone Heart, Ltd., a medical device innovator dedicated to redefining the quality in structural heart treatment, had announced the agreement done with InterValve Medical Inc., a Venus Medtech company, focuses on offering pioneering aortic valvuloplasty balloon catheters that dilate stenotic valve leaflets and the surrounding native tissue to increase aortic valve area and systemic blood flow. This agreement between the companies was done to distribute and market their balloon aortic valvuloplasty items in the US. V8 and TAV8 balloon catheters, the company's trademark devices, are the FDA-cleared aortic valvuloplasty balloon catheters with a unique 8-shaped design that is more in line with the anatomical structure of the aortic valve than conventional long cylindrical aortic valvuloplasty balloons. Both balloon catheters are used for stand-alone valvuloplasty procedures as well as procedures before and after transcatheter self-expanding heart valve repair. However, the continuous improvement by leading market players in global rheumatic heart disease drugs and development in biotechnology has brought new opportunities to the global rheumatic heart disease market.          

A Full Report of Global Rheumatic heart disease Market is Available at: https://www.omrglobal.com/industry-reports/rheumatic-heart-disease-market

Global Rheumatic Heart Disease Market Report Segment

By Treatment

Antibiotics Medication

Anti-Convulsant Medication

Anti-Inflammatory Treatment

Surgical Treatment

By Type

Valve

o          Aortic Valve

o          Mitral Valve

Myocarditis

Pericarditis

By Diagnostics Test

Electrocardiogram

Echocardiogram

Blood Test

Imaging

By End-User

Hospitals and Clinics

Diagnostic Centers

Research Centers

Global Rheumatic Heart Disease Market Report Segment by Region

North America          

US

Canada

Europe

Germany

United Kingdom

France

Spain

Italy

Rest of Europe

Asia-Pacific    

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Reasons to Buying From us –

We cover more than 15 major industries, further segmented into more than 90 sectors.

More than 120 countries are for analysis.

Over 100+ paid data sources mined for investigation.

Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rheumatic-heart-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

[shabazsayyed]

Interventional Cardiology Devices Market Demand Analysis, Emerging Trends, Innovation, Growth Development, Challenges And Forecast Outlook 2026

 The Interventional Cardiology Devices market report focuses on the economic developments and consumer spending trends across different countries for the forecast period 2019 to 2026. The research further reveals which countries and regions will have a better standing in the years to come. Apart from this, the study talks about the growth rate, market share as well as the recent developments in the Interventional Cardiology Devices industry worldwide. Besides, the special mention of major market players adds importance to the overall market study.

Companies considered and profiled in this market study

Abbott, Terumo Medical Corporation, Medtronic Inc., Boston Scientific Corporation, B Braun Melsungen, Johnson & Johnson, Ivascular, C. R. Bard, Terumo Corporation, and Biotronik.  

Scope of the Report:

To help gain the business owner further gain business intelligence the study on the Interventional Cardiology Devices market for the forecast period 2019 - 2026 brings to light data on production capability, consumption capacity, spending power, investment feasibility, and technology innovation. A thorough assessment of market performance across different regions is presented through self-explanatory graphic images, charts, and tables that add weight to corporate presentations and marketing materials. The study offers regional profiles of major vendors and extensive country-level break down to empower companies to make a wise investment decision when exploring new regions.

Get Free Sample PDF Copy of this Report@ https://www.reportsanddata.com/sample-enquiry-form/2361

Product Type Outlook (Revenue, USD Billion; 2016-2027)

·         Intravascular Ultrasound (IVUS) Catheters

·         Stents

·         PTCA Guidewires

·         Balloon Inflation Device

·         PTCA Balloons

End-user Outlook (Revenue, USD Billion; 2016-2027)

·         Homecare Setting

·         Hospital

·         Ambulatory surgical centers

·         Clinic

·         Others

Application Outlook (Revenue, USD Billion; 2016-2027)

·         Coronary angioplasty

·         Congenital heart defect correction

·         Valvuloplasty

·         Percutaneous valve repair

·         Percutaneous valve replacement

·         Coronary thrombectomy

·         Others

Knowing the trends influencing the industry performance

Stakeholders, marketing executives and business owners planning to refer a market research report can use this study to design their offerings and understand how competitors attract their potential customers and manage their supply and distribution channels. When tracking the trends researchers have made a conscious effort to analyze and interpret the consumer behaviour. Besides, the research helps product owners to understand the changes in culture, target market as well as brands so they can draw the attention of the potential customers more effectively.

Click here to Get customization & check discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/2361

Market Segment by Regions, regional analysis covers

·         North America (United States, Canada and Mexico)

·         Europe (Germany, France, UK, Russia and Italy)

·         Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

·         South America (Brazil, Argentina, Colombia etc.)

·         Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Researching target customer:

The study further talks about who are the potential customers are and where most of them are located. Besides, analysing how growth in the application has affected sales the study takes a closer look at from where and how customers purchase the products. Apart from this, insights on customer attitudes or behaviour towards the Interventional Cardiology Devices industry and the products make the document more valuable. Thus, special coverage on customer demographics, customer lifestyle trends and requirements offers everything a business owner needs to know to zero in on an effective business strategy.

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Interventional Cardiology Devices industry for the forecast period 2019-2026?

What are the major driving forces expected to impact the development of the Interventional Cardiology Devices market across different regions?

Who are the major driving forces expected to decide the fate of the industry worldwide?

Who are the prominent market players making a mark in the Interventional Cardiology Devices market with their winning strategies?

Which industry trends are likely to shape the future of the industry during the forecast period 2019-2026?

What are the key barriers and threats believed to hinder the development of the industry?

What are the future opportunities in the Interventional Cardiology Devices market?

Read More https://www.reportsanddata.com/report-detail/interventional-cardiology-devices-market 

[data-bridge-market-research]

Weight Loss and Obesity Management Market to Worth USD 299.14 billion by 2026

The global weight loss and obesity management market is expected to rise to an estimated value of USD 299.14 billion by 2026 registering a substantial CAGR of 6.70% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising pace of obesity and chronic diseases, technological advancements and the rising intake of junk food. Global Weight Loss and Obesity Management Market By Diet (Meals, Beverages, Supplements), Equipment (Fitness, Surgical), Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs), Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Get Sample Report Now @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-weight-loss-and-obesity-management-market

Some of the major market competitors currently working in the weight loss and obesity management market are Ajinomoto Co.,Inc., Herbalife International of America, Inc., Nestlé SA, PepsiCo, Johnson Health Tech., THE COCA-COLA COMPANY, Nutrisystem, Inc., Mayo Foundation for Medical Education and Research (MFMER)., Zafgen, Inc., WW International, Inc., Jenny Craig, Diet Health, Inc., VLCC, 24 Hour Fitness USA, Inc., Life Time, Inc. Abbott., GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Atkins Nutritionals, Inc., Brunswick, Kellogg NA Co., Merck & Co., Inc., Reebok International., Unilever, Precor Incorporated., ALLERGAN, Johnson & Johnson Services, Inc., Decathlon, Technogym, Apollo Endosurgery, Inc., Amer Sports, GOLD’S GYM, among others.

Key Developments in the Market:

·         In April 2017, Conyers Park and Atkins, a leading seller of nutritional food have entered into an affirmative agreement to form a new holding company, The Simply Good Foods Company. This company is expected to reach out to the masses with their health and dietary snacking space and broader food category.

·         In March, 2018 Pepsico, the giant food and beverages company has entered into an agreement to acquire the baked fruit and veggie snack maker, Bare Foods. With this acquisition, Pepsico expands its product portfolio to include dietary and healthy food, which is less processed, thereby entering the dietary and nutritional food segment. With a giant house life Pepsico, entering into the diet food segment, this market is bound to grow significantly in the forecasted period.

 Market Definition: Global Weight Loss and Obesity Management Market

Obesity it is a medical condition when excessive accumulation and storage of fats happen within the body. It impacts the health of an individual in several ways, by increasing the likelihood of chronic diseases and thereby reducing the life expectancy of individuals. The weight loss and obesity management market would include all those equipment’s, diets, devices and drugs that would be utilized for controlling or reducing weight in obese individuals.

Market Drivers

·         The rising pace of obesity is creating the need for obesity management and weight loss programs

·         Increase in the technological advancement for treatment of obesity and weight loss

·         Increasing personal disposable income

·         Increasing number of chronic diseases

·         Rising intake of high-calorie junk food and beverages especially among children and women

·         The fast growth of the fast food industry is resulting in the adoption of unhealthy lifestyles

·         Reduction in the level of physical activities due to growing luxury, which reduce the need for movement

·         Increasing awareness about healthy lifestyle, and the benefits of remaining healthy

·         Increasing government initiatives in the form of programs launched to ensure health lifestyle of people contribute to the growth of this market

·         Introduction of new and innovative products to deal with obesity and weight loss problems.

 Market Restraints

·         High cost of the obesity program, post obesity program

·         Harmful effects and complications of obesity programs hampers the growth of this market

Get Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-weight-loss-and-obesity-management-market

Segmentation: Global Weight Loss and Obesity Management Market

By Diet

·         Meals

o    Meal Replacements

o    Low-Calorie Sweeteners

o    Low-Calorie Food

o    Organic Food

·         Beverages

o    Diet Soft Drinks

o    Herbal Tea

o    Slimming Water

o    Other Low-Calorie Beverages

·         Supplements

o    Protein Supplements

o    Fiber Supplements

o    Green Tea Extract

o    Conjugated Linoleic Acid

By Equipment

·         Fitness Equipment

o    Cardiovascular Training Equipment

§  Treadmills

§  Elliptical Trainers

§  Stationary Cycles

§  RoWing Machines

§  Stair Steppers

§  Other Cardiovascular Training Equipment

o    Strength Training Equipment

§  Single-Station Equipment

§  Plate-Loaded Equipment

§  Benches and Racks

§  Multistation Equipment

§  Free Weights

§  Accessories

o    Fitness Monitoring Equipment

o    Body Composition Analyzers

·         Surgical Equipment

o    Minimally Invasive Surgical Equipment

§  Gastric Bypass Surgery Equipment

§  Laparoscopic Sleeve Gastrectomy Equipment

§  Laparoscopic Adjustable Gastric Banding Systems

§  Biliopancreatic Diversion Surgery/Duodenal Switch Equipment

§  Revision Surgery Equipment

o    Noninvasive Surgical Equipment

§  Intragastric Balloon Systems

§  Endobarrier Devices

§  Endosuturing Devices

§  Stomaphyx

·         Repair Procedures

o    Closure Procedures

o    Annuloplasty

o    Valvuloplasty

o    TMVR Procedures

By Service

·         Fitness Centers and Health Clubs

·         Slimming Centers and Commercial Weight Loss Centers

·         Consulting Services

·         Online Weight Loss Programs

By Geography

·         North America

·         South America

·         Europe

·         Asia-Pacific

·         Middle East and Africa

Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com

 Competitive Analysis: Global Weight Loss and Obesity Management Market

Global weight loss and obesity management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of weight loss and obesity management market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

·         Current and future of global weight loss and obesity management market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Order a Copy of This Research Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-weight-loss-and-obesity-management-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

[databridgemarketresearchblog]

Global Heart Valve Devices Market to Witness Robust Expansion throughout the Forecast 2026

Market Analysis: Global Heart Valve Devices Market

Global Heart Valve Devices Market is expected to rise from its initial estimated value of USD 6.45 billion in 2018 to a projected value of USD 15.41 billion by 2026, registering a CAGR of 11.50% in the forecast period of 2019-2026. This rise in market value can be attributed to growth in the levels of geriatric population and increasing prevalence of unhealthy lifestyle choices globally.

Market Definition: Global Heart Valve Devices Market

Heart valve devices can be termed as the heart valves that are used in the cardiovascular surgical procedures for the repair and replacement of worn out or damaged parts. These heart valves are used to keep the blood flowing throughout the body by pumping it and letting the blood flow in different directions.

Market Drivers:

Growing levels of innovations in technology resulting in advanced levels of product offerings has resulted in growth of demand for the product

Increasing incidences of heart diseases and cardiovascular disorders that have been a result of increase in obesity levels

Market Restraint:

Increasing levels of cost associated with the cardiovascular surgical procedure is expected to act as a restraint to the market growth

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-valve-devices-market

Segmentation: Global Heart Valve Devices Market

By Usage

By Product Type

By End-User

By Geography

Heart Valve Repair

Heart Valve Replacement

Surgical Heart Valve Repair

Percutaneous Balloon Valvuloplasty

Transcatheter Heart Valve Repair

Mechanical Heart Valves

Trans-Catheter/Percutaneous Heart Valves

Tissue/Bio-Prosthetic Heart Valves

Aortic Valves

Mitral Valves

Aortic Valves

Mitral Valves

Pulmonary Valves

Aortic Valves

Mitral Valves

Pulmonary Valves

Tricuspid Valves

Hospitals

Ambulatory Surgical Centers

North America

South America

Europe

Asia-Pacific

Middle East & Africa

US.

Canada

Mexico

Brazil

Argentina

Rest of South America

Germany

France

United Kingdom

Italy

Spain

Russia

Turkey

Belgium

Netherlands

Switzerland

Rest of Europe

Japan

China

South Korea

India

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia Pacific

South Africa

Egypt

Saudi Arabia

United Arab Emirates

Israel

Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-heart-valve-devices-market

Key Developments in the Market:

In December 2018, Meril Life Sciences Pvt. Ltd. announced the launch of artificially manufactured aortic heart valves for patients reluctant to undergo open heart valve replacement surgery. The “Trans-Catheter Aortic Heart Valve Replacement (TAVR)” will be sold under the name of “Myval”.

In January 2018, LivaNova PLC announced that they had initiated the “BELIEVE” (Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant) study. The study is initiated to identify the incidences of leaflet motion through CT imaging for the patients using LivaNova bioprosthetic aortic heart valve.

In January 2017, Abbott announced that they had completed the acquisition of St. Jude Medical, Inc. This acquisition will help in establishing Abbott as a major leader for the provision of medical devices and expanding their product portfolios significantly.

Competitive Analysis: Global Heart Valve Devices Market

Global heart valve devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of heart valve devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

[theshadowytastemakerstuden-blog1]

Global Balloon Valvuloplasty Device Market: Know The Key Growth Drivers Developments and Innovations 2019

Balloon Valvuloplasty Device Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the Balloon Valvuloplasty Device industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive Landscape, Price and Gross Margin, Balloon Valvuloplasty Device market Share via Region, New Challenge Feasibility Evaluation, Analysis and Guidelines on New mission Investment.

Download PDF Brochure for Latest Research Study @ https://www.researchmoz.us/enquiry.php?type=S&repid=1879732

This report studies the global market size of Balloon Valvuloplasty Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Balloon Valvuloplasty Device in these regions. This research report categorizes the global Balloon Valvuloplasty Device market by top players/brands, region, type and end user. This report also studies the global Balloon Valvuloplasty Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The global Balloon Valvuloplasty Device market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Balloon Valvuloplasty Device market based on company, product type, end user and key regions.

Make an Enquiry at: https://www.researchmoz.us/enquiry.php?type=E&repid=1879732

The following manufacturers are covered in this report, with sales, revenue, market share for each company: Toray Boston Palex Medical SA Terumo Tokai Medical Products Inc Edwards

Market size by Product 23 mm 26 mm 29 mm Market size by End User Hospitals Ambulatory Surgery Centres

The study objectives of this report are: To study and analyze the global Balloon Valvuloplasty Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025. To understand the structure of Balloon Valvuloplasty Device market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Balloon Valvuloplasty Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Balloon Valvuloplasty Device submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Balloon Valvuloplasty Device are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Balloon Valvuloplasty Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

About ResearchMoz ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Website: https://www.researchmoz.us Email: sales@researchmoz.us Blog: https://blogreportstudy.blogspot.com/

[randybenedict]

Teleflex picks up Essential Medical and its Manta vascular closure device

Teleflex (NYSE:TFX) said yesterday that it acquired Essential Medical and its Manta vascular closure device for an unspecified amount.

Manta is designed to close punctures at femoral arterial access sites after catheterization procedures, including transcatheter aortic valve replacements, endovascular treatment of abdominal aortic aneurysms, ventricular assist procedures and balloon aortic valvuloplasties.

Exton, Pa.-based Essential won CE Mark approval in the European Union for Manta in July 2016 and is seeking pre-market approval from the FDA. The federal safety watchdog granted an investigational device exemption for a trial of Essential’s X-Seal 6F vascular closure device in August 2016.

“We are very excited to announce this acquisition, which expands our presence in the structural heart and endovascular aneurysm repair markets. The Manta vascular closure device represents a truly innovative solution to address closure-related complications and high costs associated with many large and rapidly growing interventional procedure categories,” president & CEO Liam Kelly said in prepared remarks. “Physician adoption of the Manta device in international markets has been impressive, with over 8,100 procedures completed to date across a number of countries in the EU. We believe we can leverage our strong presence in the interventional cardiology market to accelerate adoption and growth of this breakthrough technology worldwide. Following the anticipated FDA premarket approval of the Manta device in 2019, we expect the acquisition will be modestly accretive to our constant currency revenue growth and gross margins over a multi-year period.”

“The combination of Teleflex and Essential Medical provides an excellent opportunity to maximize physician and patient access to the Manta vascular closure device,” added Essential Medical co-founder, president & CEO Greg Walters. “We are delighted to become an important part of Teleflex’s interventional cardiology business.”

The post Teleflex picks up Essential Medical and its Manta vascular closure device appeared first on MassDevice.

from MassDevice https://ift.tt/2QwSGuh

[zionmarketresearch]

Global Heart Valve Devices Market will increase by 13% Annually till 2022

Global Heart Valve Devices Market will increase by 13% Annually till 2022

Zion Market Research has published a new report titled “Heart Valve Devices Market by Procedure ( Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry…

[josephtriff-blog]

Heart Valve Devices Market Forecast to Show Spurring Growth by 2016 -2022

According to the report, global heart valve devices market was valued at approximately USD 5.60 billion in 2016 and is expected to generate revenue of around USD 10.35 billion by end of 2022, growing at a CAGR of around 13% between 2017 and 2022.

In mammals, four heart valves are there (mitral valve, tricuspid valve, aortic valve, and pulmonary valve) which responsible for keep blood flow in right direction. Sometimes, one or more of the valves don't open or close properly. This results in the blood flow through your heart to your body to be disrupted. It’s called as heart valve disease, and treatment of heart valve disease depends on the heart valve affected and the type and severity of the valve disease. Heart valve disease may require surgery to repair or replace the heart valve. Regurgitation, stenosis, and atresia are basic problems related to the heart valve. Heart valve disease can be present at birth, or it can also occur in adults due to many causes and conditions, such as infections and other heart conditions. Factors which can increase the risk of heart valve disease are older age, history of certain infections that can affect the heart, certain forms of heart disease or heart attack, high blood pressure, high cholesterol, diabetes and other heart disease risk factors, and heart conditions present at birth (congenital heart disease).

Browse Detail Report @

https://goo.gl/K6Y886

Increasing sedentary lifestyle triggering the rate of obesity and growing various cardiac diseases and pathological disorders are some of the major drivers of Heart Valve Devices Market. According to Heart Valve Society of America, more than 5 million Americans are suffering from heart valve disease. Many people left undiagnosed and untreated, as their condition can cause a progressive deterioration in heart function, which can result in heart failure and premature death. Symptoms of heart valve diseases are shortness of breath and/or difficulty catching your breath, discomfort in your chest, weakness, irregular heartbeat, swelling of your ankles, feet or abdomen and rapid weight gain. This symptom may occur or may not in some people; it slowly develops and worsens over time which may cause the death of a person. However, complex regulatory procedures and the high price of devices and procedure may hamper the growth of the heart valve devices market. However, growth in transcatheter heart valves and demand for heart valve devices in the Asia Pacific region may create a significant opportunity for heart valve devices market in the coming years.

The Heart Valve Devices Market is classified based on procedure, end-user, and region. On the basis of procedure, the market is divided into heart valve replacement devices and heart valve repair devices. Heart valve replacement devices are further sub-segmented on the basis of techniques as a mechanical valve, Bioprosthetic valve and TAVR (Transcatheter Aortic Valve Replacement). Heart valve replacement devices are further sub-segmented on the basis of the position where they are replaced as mitral valve replacement devices, aortic valve replacement devices, and other position heart valve replacement devices. Heart valve repair devices are further sub-segmented on the basis of techniques as surgical valve repair devices, balloon valvuloplasty devices and TMVR (Transcatheter Mitral Valve Repair). Due to the escalating use of technologically superior products, more than average selling prices, and considerably lower mortality rate achieved by the devices, the transcatheter heart valve devices accounts for maximum share in the market. On the basis of the end-user market is divided into hospitals and ambulatory surgical centers.

Request for Free Sample Report @

https://goo.gl/bHmaEp

(Purchase Single User License at $4199)

By geography, North America dominates the Heart Valve Devices Market owing rising usage of technologically superior products in this region. Other major driving factors in the North America region is increasing rate of obesity and prevalence of cardiac diseases in this region. Additionally, the presence of major market players, such as Boston Scientific Corporation, Abbott, and Medtronic, in the U.S. is anticipated to contribute significantly to the revenue generation of the country. Europe is also a major market for heart valve devices market due to supportive policies of the government, number of product launches, and a large pool of elderly highly susceptible to various heart diseases.

In Asia Pacific region due to the high prevalence of heart valve diseases and developing healthcare, infrastructure creates significant opportunity in the near future. The Middle East and Africa are anticipated to witness significant growth during the forecast period.

Request to view Report TOC (Table of Contents) @

https://goo.gl/ohbPfb

Some of the key players in Heart Valve Devices Market include Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.

About Us :

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

[hillcountrytimes]

Snow Capital Management LP Increased Mellanox Technologies LTD (MLNX) Stake; CR Bard (BCR) Shorts Increased By 8.9%

CR Bard Incorporated (NYSE:BCR) had an increase of 8.9% in short interest. BCR’s SI was 1.22M shares in December as released by FINRA. Its up 8.9% from 1.12M shares previously. With 414,400 avg volume, 3 days are for CR Bard Incorporated (NYSE:BCR)’s short sellers to cover BCR’s short positions. The SI to CR Bard Incorporated’s float is 1.7%. The stock increased 0.35% or $1.17 during the last trading session, reaching $337.11. About 94,518 shares traded. C. R. Bard, Inc. (NYSE:BCR) has risen 40.70% since December 1, 2016 and is uptrending. It has outperformed by 24.00% the S&P500.

Snow Capital Management Lp increased Mellanox Technologies Ltd (MLNX) stake by 24.03% reported in 2017Q2 SEC filing. Snow Capital Management Lp acquired 159,447 shares as Mellanox Technologies Ltd (MLNX)’s stock declined 3.98%. The Snow Capital Management Lp holds 823,103 shares with $35.64M value, up from 663,656 last quarter. Mellanox Technologies Ltd now has $3.00 billion valuation. The stock decreased 0.25% or $0.15 during the last trading session, reaching $58.95. About 217,598 shares traded. Mellanox Technologies, Ltd. (NASDAQ:MLNX) has risen 12.09% since December 1, 2016 and is uptrending. It has underperformed by 4.61% the S&P500.

Among 15 analysts covering CR Bard (NYSE:BCR), 4 have Buy rating, 0 Sell and 11 Hold. Therefore 27% are positive. CR Bard had 32 analyst reports since August 27, 2015 according to SRatingsIntel. Wells Fargo upgraded the shares of BCR in report on Friday, September 16 to “Outperform” rating. The stock of C. R. Bard, Inc. (NYSE:BCR) earned “Neutral” rating by Bank of America on Friday, July 8. The firm has “” rating by Raymond James given on Wednesday, April 26. On Thursday, January 5 the stock rating was upgraded by Raymond James to “Strong Buy”. The company was maintained on Wednesday, July 27 by Barclays Capital. The stock of C. R. Bard, Inc. (NYSE:BCR) earned “Buy” rating by Citigroup on Thursday, November 12. Zacks downgraded the shares of BCR in report on Monday, September 7 to “Hold” rating. On Tuesday, September 12 the stock rating was maintained by Jefferies with “Hold”. Jefferies maintained it with “Hold” rating and $31700 target in Thursday, June 29 report. The firm earned “Hold” rating on Wednesday, October 11 by BMO Capital Markets.

Investors sentiment decreased to 0.58 in Q2 2017. Its down 0.30, from 0.88 in 2017Q1. It turned negative, as 99 investors sold C. R. Bard, Inc. shares while 273 reduced holdings. 103 funds opened positions while 111 raised stakes. 55.14 million shares or 10.97% less from 61.93 million shares in 2017Q1 were reported. Comerica National Bank accumulated 24,405 shares. Strs Ohio owns 4,899 shares. Tetrem Mngmt holds 0.01% in C. R. Bard, Inc. (NYSE:BCR) or 750 shares. Finemark Natl Bank Tru owns 2,337 shares or 0.05% of their US portfolio. Shine Invest Advisory Services holds 0.02% in C. R. Bard, Inc. (NYSE:BCR) or 129 shares. Capstone Asset Mngmt accumulated 0.1% or 11,164 shares. Raymond James Assoc holds 0.01% in C. R. Bard, Inc. (NYSE:BCR) or 10,466 shares. Steinberg Glob Asset Mngmt, a Florida-based fund reported 3,265 shares. Old Mutual Customised Solutions (Proprietary) Limited has invested 0.07% in C. R. Bard, Inc. (NYSE:BCR). Berkshire Asset Mngmt Lc Pa has 0.04% invested in C. R. Bard, Inc. (NYSE:BCR) for 1,100 shares. Schwab Charles Inv accumulated 0.07% or 240,591 shares. Employees Retirement Association Of Colorado holds 0.03% or 14,299 shares. York Capital Global Advisors Limited Liability Com has invested 2.56% in C. R. Bard, Inc. (NYSE:BCR). 21,381 were reported by Wellington Management Group Llp. Everett Harris And Company Ca has 0.02% invested in C. R. Bard, Inc. (NYSE:BCR).

C. R. Bard, Inc., together with its subsidiaries, designs, makes, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company has market cap of $24.57 billion. The firm offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It has a 44.26 P/E ratio. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia.

Snow Capital Management Lp decreased American International Group I (NYSE:AIG) stake by 80,885 shares to 42,101 valued at $2.63M in 2017Q2. It also reduced Zebra Technologies Crp A (NASDAQ:ZBRA) stake by 542,654 shares and now owns 45,968 shares. Skyworks Solutions Inc (NASDAQ:SWKS) was reduced too.

Investors sentiment decreased to 0.93 in Q2 2017. Its down 0.16, from 1.09 in 2017Q1. It dived, as 20 investors sold MLNX shares while 53 reduced holdings. 31 funds opened positions while 37 raised stakes. 29.75 million shares or 9.85% less from 32.99 million shares in 2017Q1 were reported. Alliancebernstein LP invested in 0.04% or 1.06M shares. Jane Street holds 0.02% or 116,053 shares in its portfolio. Millennium Mngmt has invested 0.03% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Harber Asset Ltd Liability reported 74,633 shares or 1.33% of all its holdings. Bluefin Trading Lc stated it has 0.03% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX). 99,068 were accumulated by Citadel Limited Liability Company. Riverpoint Mngmt Ltd Liability Company reported 260,513 shares stake. Engineers Gate Manager LP has invested 0.19% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). 1,124 were accumulated by Independent Portfolio Consultants Incorporated. Magnetar Fincl Limited Liability reported 4,968 shares stake. Janney Montgomery Scott Llc holds 0% or 4,936 shares. Ubs Asset Americas, Illinois-based fund reported 21,011 shares. Commercial Bank Of New York Mellon Corporation has invested 0.01% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Legal General Grp Incorporated Public Limited, United Kingdom-based fund reported 4,488 shares. Focused Wealth Management Inc invested 0.02% in Mellanox Technologies, Ltd. (NASDAQ:MLNX).

Among 17 analysts covering Mellanox Tech (NASDAQ:MLNX), 9 have Buy rating, 1 Sell and 7 Hold. Therefore 53% are positive. Mellanox Tech had 40 analyst reports since July 23, 2015 according to SRatingsIntel. Roth Capital maintained Mellanox Technologies, Ltd. (NASDAQ:MLNX) rating on Monday, July 24. Roth Capital has “Hold” rating and $5300 target. Stifel Nicolaus maintained it with “Buy” rating and $56.0 target in Monday, September 25 report. The firm has “Buy” rating given on Thursday, September 24 by DA Davidson. Stifel Nicolaus maintained Mellanox Technologies, Ltd. (NASDAQ:MLNX) rating on Thursday, October 26. Stifel Nicolaus has “Buy” rating and $53 target. The stock of Mellanox Technologies, Ltd. (NASDAQ:MLNX) earned “Buy” rating by Benchmark on Tuesday, August 29. The stock of Mellanox Technologies, Ltd. (NASDAQ:MLNX) earned “Buy” rating by Topeka Capital Markets on Wednesday, February 24. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 23. The company was maintained on Thursday, January 28 by Stifel Nicolaus. The company was reinitiated on Thursday, February 25 by JP Morgan. The firm has “Buy” rating given on Tuesday, June 21 by Summit Redstone Partners.

The post Snow Capital Management LP Increased Mellanox Technologies LTD (MLNX) Stake; CR Bard (BCR) Shorts Increased By 8.9% appeared first on Stock Market News | HillCountryTimes | Get it Today.

from Stock Market News | HillCountryTimes | Get it Today https://www.hillcountrytimes.com/2017/12/01/snow-capital-management-lp-increased-mellanox-technologies-ltd-mlnx-stake-cr-bard-bcr-shorts-increased-by-8-9/